Admissions:
Winking Studios (WKS.L), the AAA Art Outsourcing and Game Development business, has announced its Admission of its shares to trading on the AIM Market. The group raised £7.9m by way of a placing. Based on the placing price of 15 pence per share, the Company’s market capitalisation on Admission will be approximately £66m. The company ranks fourth globally in game Art Outsourcing and third in Asia. Winking works with the world’s top game developers including Activision, EA and Ubisoft on major franchises including Call of Duty, FIFA and Assassin’s Creed. Winking Studios is dual listed on the Catalist board of the Singapore Exchange Securities Trading Limited (SGX:WKS).
Delistings:
None
Potential **** Initial Public Offerings:
ActiveOps 111p £79.2m (AOM.L)
The provider of Decision Intelligence for service operations announced its unaudited results for the six months ended 30 September 2024. Total revenue was up 10% to £14.32m, gross margin remained flat at 84% and profit before tax grew 370% to £0.47m. Balance sheet remains debt free with £13.44m cash and cash investments (H1 FY24: £9.90m). The Board anticipates delivering results for the year ending 31 March 2025 in line with its current expectations.
AdvancedAdvT 143.5p £191.1m (ADVT.L)
The software solutions provider for business, compliance, and resource management has published its unaudited interim results for the six months to 31 August 2024, following the Group's change of year end to 28 February. Revenue reported from continuing operations up 31% to £19.9m (6m to December 2023: £15.1m) and recurring revenue represented 80% of total revenues (6m to December 2023: 76%). Adjusted EBITDA grew by 8% to £4.0m - ahead of management expectations (6m to December 2023: £3.7m). Cash of £83.3m at 31 August 2024 (February 2024: £82.1m). In addition, the Group holds a 9.8% stake in M&C Saatchi Plc valued at £25.1m on 31 August 2024.
Corero 23.5p £120.4m (CNS.L)
The distributed denial of service (DDoS) protection specialists announced that the Company has made good progress during Q4 2024 to date securing new contracts for its SmartWall ONE DDoS protection solutions. Q4 2024 has seen continued momentum with the addition of new customer mandates and upselling into existing customers across multiple selling regions. Total contract value secured Q4 2024 to date is $1.7m.
Global Petroleum 0.22p £8.5m (GBP.L)
The exploration Company announced results of an Airborne Aeromagnetic Survey at Juno. The Company's main focus at Juno is targeting Intrusion Related Gold Systems similar to Havieron and Telfer. Havieron and Telfer are large gold and copper deposits located in the north of Western Australia. The new aeromagnetic data confirms the location, highlights the strong intensity and verifies the large size of the Juno magnetic feature. This new detailed aeromagnetic data reveals structures and other features not seen in historical, lower resolution, magnetic data.
Itaconix 136p £18.3m (ITX.L)
The innovator in plant-based specialty polymers used to decarbonise everyday consumer products announced a collaboration agreement with Bonals Technologies under the Company's SPARX program to speed the introduction of safer, better performing, and more sustainable unit dose detergent tablets in the US and Canada. Bonals is based in Saint-Just-Saint-Rambert, France and produces tableting equipment that is used by leading detergent tablet brands and contract manufacturers in Europe. Under the agreement, Itaconix will work with Bonals and leading North America detergent suppliers on new generations of detergents that seek to leverage the synergistic benefits of Itaconix tablet formulations produced on Bonals equipment.
Kodal Minerals 0.34p £69.9m (KOD.L)
The mineral exploration and development Company provided an update on the progress of construction of the Stage 1 Dense Media Separation processing plant and mining at the Ngoualana open pit mine at its flagship Bougouni Lithium Project in Southern Mali. The Project is fully funded through the US$117.5m Hainan funding transaction. The start of production at Bougouni remains on track for the first quarter of 2025 and remains within the US$65m capital development budget. Assay results have been received for the majority of the Boumou prospect diamond drilling programme, which confirms consistent wide, high grade drill intersections.
Novacyt 49.35p £34.9m (NCYT.L)
The molecular diagnostics Company with a broad portfolio of integrated technologies and services announces that it is launching two new assays for gastrointestinal disease in dogs and cats at the London Vet Show, held today. The genesig PLEX kits for Canine and Feline Gastrointestinal (GI) Diseases are multiplexed qPCR assays that detect six disease-causing pathogens in the digestive system of cats and dogs in a two-tube assay, delivering a streamlined and efficient testing solution for centralised veterinary laboratories. Each target has been carefully selected to detect a key pathogen that can cause potentially serious or life-threatening GI illnesses in cats and dogs.
Phoenix Copper Limited 5.75p £10.8m (PXC.L)
The USA-focused base and precious metals emerging producer and exploration Company announced an update regarding the US$80m corporate copper bond subscription, originally announced on 15 May 2024, of which an initial tranche of US$5m was drawn down in June 2024. NIU Invest SE, the bond subscriber, is currently reviewing the Empire Mine project data, prior to finalising a new drawdown schedule which will be based on the updated project economics included in the Empire Mine open-pit Pre-Feasibility Study, published on 19 September 2024. The Company remains in discussions with a number of other potential bond investors in order to ensure appropriate financing is in place for exploration throughout the Empire mineralised district.
Plexus Holdings 9.75p £10.3m (POS.L)
The specialist wellhead engineering business announced a new order to supply its Exact exploration wellhead equipment on a rental basis, along with associated services, for an offshore gas exploration project in the Middle East. The project, set to generate approximately $1m in revenue, is expected to begin in the second half of 2025. This order, which is still subject to contract finalisation, was secured in partnership with Peak Energy Solutions, with whom Plexus has collaborated for the past two years to establish the necessary local licenses and customer registration for operations in the region.
SRT Marine Systems 40p £89.1m (SRT.L)
The developer of maritime domain awareness technologies announced that the Retail Offer launched on 13 November 2024 has now closed, raising in aggregate £0.95m at a price of 35 pence each. Accordingly, conditional on the passing of the Fundraising Resolutions at the General Meeting and Admission, the Company has conditionally raised total gross proceeds of approximately £8.5m in aggregate by way of the Fundraising.
.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
